ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

HHA “Investigative Memorandum” Revives Controversy Over AIDS Virus, Royalties

July 1, 1994

Researchers Link Obesity With 34% Higher Death Risk In Pre-Menopausal Women

May 30, 2014

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

NCI-Approved Clinical Trials

May 26, 2006